Monday, 13 February 2012

Nordic companies at 14th Annual BIO CEO & Investor Conference

Several Nordic biopharmaceutical companies are presenting at the 14th Annual BIO CEO & Investor Conference in New York today and tomorrow. These two companies are presenting shortly:

Zealand Pharma A/S (OMX: ZEAL) 2.00 PM EST 20.00 CET
Biotie Therapies Corp. (OMXH: BTH1V) 2.30 PM EST 20.30 CET

Their presentations should be webcasted here (available for review later).

Other companies presenting today include Azanta A/S and Novozymes A/S (OMX: NZYM B). Bavarian Nordic A/S (CPH: BAVA) and Veloxis Pharmaceuticals (OMX: VELO, formerly LifeCycle Pharma A/S) are scheduled to present tomorrow.

No comments:

Post a Comment